Medco to acquire United BioSource for $730M
Medco Health Solutions has signed a definitive agreement to acquire United BioSource in an all-cash transaction valued at approximately $730 million.
The Bethesda, Md.-based United BioSource offers safety and risk management, health economics and outcomes research on post-approval drugs and devices to pharmaceutical companies and medical device manufacturers.
The transaction, which will be funded through Medco’s free cash and existing debt facilities, is expected to close in the third quarter, according to the Franklin Lakes, N.J.-based Medco, a pharmacy benefits management firm.
When the deal is completed, United BioSource will become a wholly owned, independently run subsidiary of Medco.
The Bethesda, Md.-based United BioSource offers safety and risk management, health economics and outcomes research on post-approval drugs and devices to pharmaceutical companies and medical device manufacturers.
The transaction, which will be funded through Medco’s free cash and existing debt facilities, is expected to close in the third quarter, according to the Franklin Lakes, N.J.-based Medco, a pharmacy benefits management firm.
When the deal is completed, United BioSource will become a wholly owned, independently run subsidiary of Medco.